No brainer for BrainZ
Wednesday, 08 October, 2008
BrainZ Instruments [ASX: BZI] is to be acquired by the US-based Natus Medical for NZ$1.3 million [AUD$1.13 million].
Pending shareholder approval, Natus will acquire essentially every trading asset of BrainZ - including products, IP and brand – except the company's cash reserves.
If the arrangement goes ahead, Natus will assume a number of the company’s distribution and customer support obligations.
BrainZ has developed a bedside brain monitoring technology that assists in the detection of brain injury and seizure activity in neonates.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
